LNSR
LENSAR, Inc.
There isn't enough reported data to score LNSR yet.
LNSR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Strong |
LNSR's revenue and balance sheet are currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow.
LNSR PE Valuation
LNSR has no meaningful PE right now: it lost money over the past year.
LNSR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect LNSR's losses to grow, with revenue growing.
LNSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$2.87 | -$0.14 |
| Q3 2025 | -$4.40 | -$2.96 |
| Q2 2025 | -$4.22 | -$2.68 |
| Q1 2025 | -$4.86 | -$3.30 |
| Q4 2024 | -$2.73 | -$0.96 |
| Q3 2024 | -$1.44 | +$0.23 |
| Q2 2024 | -$1.54 | +$0.29 |
| Q1 2024 | -$1.56 | +$0.13 |
LNSR lost $2.87 per share over the past year, about the same as its loss the year before.
LNSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.1M | -1.3% |
| Q2 2026 | $16.5M | +18% |
| Q1 2026 | $13.4M | -5.2% |
| Q4 2025 | $16M | -4.2% |
| Q3 2025 | $14.3M | +5.7% |
| Q2 2025 | $13.9M | +10% |
| Q1 2025 | $14.2M | +34% |
| Q4 2024 | $16.7M | +38% |
LNSR's revenue fell from its 2024 peak and has held roughly level since: $14M last quarter, down 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +43 points |
| Q2 2026 | 13% | +58 points |
| Q1 2026 | 17% | +58 points |
| Q4 2025 | -31% | -23 points |
| Q3 2025 | -53% | -44 points |
| Q2 2025 | -45% | -3.3 points |
| Q1 2025 | -41% | -14 points |
| Q4 2024 | -7.7% | +17 points |
LNSR's operating margin was −10% last quarter, up 43 points from the same quarter a year ago.
LNSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$978K | +$2.5M |
| Q4 2025 | $618K | -83% |
| Q3 2025 | -$3.5M | -212% |
| Q2 2025 | -$5.1M | -$1.2M |
| Q1 2025 | -$6.9M | -$1.6M |
| Q4 2024 | $3.7M | +$4.2M |
| Q3 2024 | $3.1M | +$3.5M |
| Q2 2024 | -$3.9M | -$1.6M |
LNSR has burned cash in almost every quarter: −$9M over the past year, against −$4M the year before.
LNSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -46% | -10.6M shares |
| 1 year | +3.9% | +461K shares |
| 3 years | +15% | +1.6M shares |
| 5 years | +33% | +3.1M shares |
| Available history | +17% | +1.8M shares |
LNSR has 12M diluted shares, up 3.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
LNSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.3x | Net Cash |
LNSR has more cash than debt.
LNSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.2 | Neutral |
| Stochastic | 12.6 | Oversold |
LNSR's weekly RSI is 34 (neutral) and its Stochastic is 13 (oversold).
LNSR PE vs Healthcare Sector
LNSR has no meaningful PE right now: it lost money over the past year.
LNSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.99 | 22% below |
| 20 week MA | $6.56 | 28% below |
| 50 week MA | $7.88 | 40% below |
| 100 week MA | $10.0 | 53% below |
| 200 week MA | $6.92 | 32% below |
LNSR is in a downtrend: it's below all five of its weekly moving averages, and 32% below its 200-week average.
LNSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.00 | $6.86 | -24% |
| 2021 | $6.86 | $6.00 | -13% |
| 2022 | $6.00 | $2.77 | -54% |
| 2023 | $2.77 | $3.51 | +27% |
| 2024 | $3.51 | $8.38 | +139% |
| 2025 | $8.38 | $12.0 | +43% |
| 2026 YTD | $12.0 | $4.70 | -61% |
LNSR's yearly returns have swung widely, from +139% in 2024 to −54% in 2022. It's down 61% so far in 2026.